Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04799665 · ClinicalTrials.gov registry record
Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizona
A clinical trial, sponsored by University of Arizona.
- Completed
- Registry status
- 92
- Enrollment target
NCT04799665: Completed study, sponsored by University of Arizona.
NCT04799665 is a clinical trial that has completed, run by University of Arizona. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04799665 has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The overall objective of this clinical study is to determine the feasibility of breast CT for breast density assessment and association of CT-derived density measures with metabolic syndrome in overweight/obese Mexican-origin women in Southern Arizona. These evaluations will help support follow-up clinical research utilizing breast density acquired by breast CT as a surrogate endpoint biomarker to evaluate breast cancer preventive strategies. The long-term goal of these research efforts is to develop safe and effective preventive strategies to reduce obesity-associated breast cancer burden in our catchment area.
Primary Outcome
To determine the feasibility of applying a novel clinical prototype of breast CT to assess breast density on non-compressed breasts. Feasibility will be evaluated by the proportion of unmeasurable breast density within our study population utilizing computerized tomography (CT) scan.
Interventions
- DIAGNOSTIC_TEST Breast CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2024-05-01 |
What the finished NCT04799665 record still lists
NCT04799665 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Breast CT is the first listed.
NCT04799665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04799665 about?
NCT04799665 is a clinical study titled "Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizona". The overall objective of this clinical study is to determine the feasibility of breast CT for breast density assessment and association of CT-derived density measures with metabolic syndrome in overweight/obese Mexican-origin women in Southern Arizona. These evaluations will help support follow-up c...
What is the current status of trial NCT04799665?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2022-04-28. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT04799665?
The interventions under investigation include: Breast CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04799665?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI